Circle Pharma Announces Upcoming Presentation at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

[#item_full_content]SAN FRANCISCO–(BUSINESS WIRE)–Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, today announced an upcoming poster presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place from October 11-15, 2023, in Boston, MA. Details of the presentation are as follows: Title:   Novel orally bioavailable macrocycles that target cyclin A and B elicit antitumor activity